Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
12
×
fda
12
×
biotech
life sciences
national blog main
boston blog main
clinical trials
national top stories
boston top stories
national
new york blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
eli lilly
europe blog main
startups
astrazeneca
bristol-myers squibb
cancer
cancer immunotherapy
europe top stories
ipo
What
bio
roundup
fda
companies
drug
health
medicine
new
treatment
approved
biotech
days
medicines
news
week
won
years
abbvie’s
acquisitions
addition
adults
advance
ahead
alkermes
allergan
alzheimer’s
anemia
announced
annual
antipsychotic
apple
approves
apps
assessed
attention
august
benefit
benefits
biofourmis
biopharma
Language
unset
Current search:
abbvie
×
fda
×
@extremetech.com
2 years ago
FDA Approves New Eye Drops that Could Replace Glasses for Millions
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@techcrunch.com
4 years ago
What top VCs look for in women’s fertility startups
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More